ClinicalTrials.gg
CompletedNCT00891098Updated Jun 5, 2013

Comparing Imaginal Exposure and Imagery Rescripting in Treatment of Posttraumatic Stress Disorder (PTSD)

An interventional study of Imaginal exposure and Imagery rescripting in Posttraumatic Stress Disorder, sponsored by Modum Bad. Completed at 1 site in Norway. Open to participants aged 20 Years to 65 Years. Per ClinicalTrials.gov, last updated 2013-06-05.

Sponsored by Modum Bad · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Randomized
Ages
20 Years to 65 Years
Sex
All
01

Study summary

The outcome of trauma treatment (Posttraumatic Stress Disorder - PTSD) may be influenced by which emotions that are predominant among current symptoms, e.g. fear, anger, guilt, shame. Different treatment procedures for processing traumatic memories may resolve different emotions. This study compares two different treatment procedures of working with trauma memories in PTSD treatment (namely, Imaginal Exposure and Imagery Rescripting) in order to test this.

Read the detailed description

The main objectives of this study are:

  1. To assess the relative efficacy of the two procedures in inpatient treatment for PTSD
  2. To assess whether the predominant emotions in the traumatic memories moderate the outcome of the different procedures
  3. To assess whether theory-derived constructs mediate outcome and whether the mediating relationships are different in the two treatments
  4. To provide a theoretical account of the two models
  5. To psychometrically evaluate 3 new measures
02

Conditions studied

  • Posttraumatic Stress Disorder
03

In context

Stress Disorders, Post-Traumatic

2,284 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 557 are open to participants now.

This study's enrollment of 65 is close to the median of 70 across 1,897 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Modum Bad is the lead sponsor of 19 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • DSM-IV diagnosis of PTSD identified as primary diagnosis
  • Accepts withdrawal of all psychotropic medication

Exclusion criteria

Exclusion Criteria:

  • Extensive dissociative symptoms or current psychosis,
  • Current suicidal risk,
  • Extensive current substance or alcohol abuse, or
  • Ongoing trauma
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
65 participants (actual)

Study arms

  • Active comparator
    Imaginal exposure

    Behavioral: Imaginal exposure

  • Experimental
    Imagery rescripting

    Behavioral: Imagery rescripting

Interventions

  • BehavioralImaginal exposure

    7 individual sessions of imaginal exposure of trauma memories according to the prolonged exposure treatment manual

    Also known as: prolonged exposure, pe

  • BehavioralImagery rescripting

    7 individual sessions of imagery rescripting of trauma memories according to the imagery rescripting and reprocessing therapy manual

    Also known as: rescripting, irrt

06

What researchers measure

Primary outcomes

  1. PTSD symptoms

    Time frame: pretreatment, weekly during treatment, posttreatment, followup

Secondary outcomes

  1. General psychiatric symptoms

    Time frame: pretreatment, weekly during treatment, postttreatment, followup

07

Study locations

1 site
  • Modum Bad
    Vikersund, Buskerud 3370, Norway
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 5, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00891098
Lead sponsor
Modum Bad
Collaborators
University of Oslo
Responsible party
Asle Hoffart (phd, Modum Bad) — Principal investigator
First posted
May 1, 2009
Start date
Nov 2008
Primary completion
Nov 2012
Completion
Nov 2012
Last update
Jun 5, 2013

Study contacts

Asle Hoffart, PhD
study chair · Modum Bad and University of Oslo

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion